Visual function status in myopic patients before and after pharmacological correction of antioxidant defense system failure

E.I. Surova

I.M. Boichuk, Dr. Sc. (Med)

Filatov Institute of Eye Diseases and Tissue Therapy

Odessa, Ukraine

E-mail: iryna54@mail.ru

Background: Recent studies of the clinical features and pathogenesis of the acquired, progressive and complicated myopia have evidenced that patients with this disease have reduced antioxidant defense. It is hypothesized that pharmacological correction of antioxidant defense system failure will improve visual functions in myopes.

Purpose: To assess the status of visual functions (including distance visual acuity, absolute reserve of accommodation and photopic light sensitivity) in patients with myopia of different degrees before and following treatment with an antioxidant medication (Fakovit).

Materials and Methods: The Fakovit treatment group included 70 myopes (140 eyes) (mild myopes, n = 28; medium myopes, n = 22; high myopes, n = 20), whereas the control group included 30 aged matched myopes who did not receive Fakovit treatment. All patients underwent ophthalmic examinations including refractometry, biomicroscopy, echobiometry, ophthalmoscopy, and absolute reserve of accommodation. The uncorrected and corrected distance visual acuities (VA) were assessed using the Shevalev’s Chart, and absolute reserve of accommodation (RA) was assessed using a conventional technique. Photopic light sensitivity was assessed with the use of semi-automatic registering adaptometer.

Results: An improvement in VA was achieved in 86.1% of mild and medium myopes of the treatment group. An improvement in and stabilization of RA was found in 44.4% (mainly, in mild myopes) and 38.8%, respectively, of the patients of the treatment group, and a 1.43±1.29-D reduction in RA (p < 0.05) was observed in the control group. Photopic light sensitivity of the visual system had a tendency to increase in all myopes after treatment with Fakovit (in particular, it increased statistically significantly by 0.16±0.04 log units in mild myopes), and did not change in the controls.

Conclusion: Correction of antioxidant defense system failure with Fakovit improved and stabilized visual functions (visual acuity, reserve of accommodation, and photopic light sensitivity) in myopic patients.

Key words: pharmacological correction, antioxidant defense system, reduced antioxidant defense, myopia.   


1.        Avetisov ES. [Myopia]. Moscow: Meditsina; 1986. 240 p. Russian

2.        Bushuieva NN. [Current aspects of etiology, pathogenesis and surgical treatment of progressive myopia]. Oftalmol Zh. 2006;3(1):65-70. Russian

3.        Vladimirov IuA, Archakov AI. [Lipid peroxidation in biological membranes]. Moscow: Nauka; 1970. 252 p. Russian

4.        Vinetskaia MI, Kushnarevich NIu, Tarutta EP, Demchuk ML. [Investigation of indices of tear oxidation by free radicals in progressive myopia]. In: [Current Issues in Ophthalmology. Proceedings of the Conference on the 170th Anniversary of Moscow City Ophthalmological Clinical Hospital]; 1996; Moscow; p.51-2. Russian

5.        Kozlov IuP. [Structural and functional aspects of lipid peroxidation in biological membranes]. In: [Lipids: structures, biosynthesis, transformations and functions. Collection of scientific papers.] p.80-93. Russian

6.        Stotska LM, Serdiuchenko VI. [Efficiency of spirulina bio-regulator in the treatment of uncomplicated acquired myopia in children and adolescents]. Oftalmol Zh. 2005;3:36-40. Ukrainian

7.        Tarutta EP. [Potential for prevention of progressive and complicated myopia in light of current knowledge on pathogenesis of this disease]. Vestn Oftalmol. 2006;1:43-7. Russian

8.        Metelitsyna IP, Stotskaia LM, Serdiuchenko VI. [Efficacy of spirulina in treatment of myopia in children based on biochemical and clinical indices]. Oftalmol Zh. 2004;6:54-8. Russian

9.        Rykov SO. [Prevention of ocular disorders in children. Guidance manual]. Kyiv: SPT Bavok; 2003. 64 p. Ukrainian

10.     Lee J, Lee HK, Kim CY et al. Purified high-dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects. Br J Nutr. 2005;93(6):895-9.
        Crossref   Pubmed

11.     Iurevych OIu. [Clinical and experimental basis for correction of impaired thiol metabolism in patients with age-related macular dystrophy]. [Abstract for Cand. Sc. (Med) Thesis]. Odessa: Filatov Institute of Eye Diseases and Tissue Therapy; 2005. 16 p. Ukrainian

12.     Surova EI, Boichuk IM, Kolomiichuk SG. [Status of blood antioxidant enzyme system in patients with different degrees of myopia before and after pharmacological correction of system failure]. Oftalmol Zh. 2014;6:34-9. Russian